"Designing Growth Strategies is in our DNA"

Blood Transfusion Diagnostics Market Size, Share & COVID-19 Impact Analysis, By Product (Instruments, and Reagents & Kits), By Application (Blood Screening, and Blood Group Typing), By End User (Hospital-based Laboratories, and Independent Laboratories & Blood Banks) and Regional Forecast 2021-2028

Region : Global | Format: PDF | Report ID: FBI100596

 

KEY MARKET INSIGHTS

Play Audio Listen to Audio Version

The global blood transfusion diagnostics market size was USD 4.13 billion in 2020. The impact of COVID-19 has been unprecedented and staggering, with blood transfusion diagnostics witnessing a negative impact on the adoption rate across all regions amid the pandemic. Based on our analysis, the global market exhibited a slower growth of 3.1% in 2020 as compared to the average year-on-year growth during 2017-2020. The market is projected to grow from USD 4.39 billion in 2021 to USD 7.08 billion in 2028 at a CAGR of 7.1% in the 2021-2028 period. The rise in CAGR is attributable to this market’s demand and growth, returning to pre-pandemic levels once the pandemic is over.


Blood transfusion diagnostics is referred to tests that are performed on blood and blood components before transfusing them to patients. Each blood unit must be tested for blood group typing and disease screening in order to prevent adverse reactions or transmission of any infection. It is a crucial part of transfusion therapy, which provides critical information to healthcare professionals and confirms the compatibility of donors and recipient blood samples.


Cancellation of Blood Drives and Reduction in Number of Voluntary Blood Donations Resulting in Slower Market Growth


The outbreak of Covid-19 has had a negative effect on the market. The pandemic has resulted in a decline in the number of voluntary blood donations and disrupted the supply chain of medical devices worldwide. Diminished donor inflow, lack of staff personnel, shortage of blood units, and concerns about transfusion-transmitted COVID-19 among people were some of the major challenges faced by blood banks and hospitals during the crisis.


For instance, according, to the American Red Cross, it was estimated that the organization lost around 46,000 blood unit donations as a result of the pandemic. Also, few donor centers experienced a dramatic reduction in blood donations due to the implementation of lockdown and the cancellation of blood drives.


However, most of the major countries lifted lockdown and stay-home regulations by the third quarter of 2020, which resulted in increasing blood donations and transfusion procedures across all blood centers.


LATEST TRENDS


Request a Free sample to learn more about this report.


Shift Toward Automated Molecular Platforms to Accelerate the Market Growth


The introduction of advanced molecular platforms by market key players is increasing the shift from manual tests and instruments toward semi-automated and fully automated instruments. These automated platforms have been pivotal in the rapid detection of Transfusion Transmissible Infections (TTI’s) in blood samples and can precisely eliminate human error during the transfusion process.


For instance, in June 2017, Grifols, S.A., launched Erytra Eflexis, a fully automated mid-size analyzer in the market. This new analyzer was intended to perform pretransfusion compatibility testing using DG Gel technology and optimize the workflow in laboratories and blood banks.


Thus, the launch of such advanced automated systems has been instrumental in fueling the adoption of blood transfusion diagnostics and is expected to further drive the growth of the market during the forecast period.


DRIVING FACTORS


Increasing Demand for Blood and Blood Components to Boost the Demand


The growing prevalence of blood-related disorders, such as hemophilia, cancer, thrombocytopenia, etc., and chronic kidney disease (CKD), has propelled the demand for blood products and complete blood transfusion. 



  • For instance, according to the data published by World Kidney Day, in 2020, around 850 million people worldwide were suffering from kidney disorders. Also, it was observed that one in ten adults suffers from chronic kidney disease (CKD) and this condition is expected to become the fifth most common cause of death by the end of 2040.


Also, the increasing number of patients suffering from anemia, which requires red blood cell transfusion for its treatment, is anticipated to upsurge the demand for blood transfusion diagnostics. For instance, according to the estimations of the World Health Organization (WHO), anemia affects around 1.62 billion people across the world.


This, along with the increasing awareness regarding blood safety from infectious diseases through several programs in developed and emerging countries is resulting in high demand for blood screening tests and other diagnostic tools. Thus, the above factors are increasing the demand for transfusion diagnostics and are subsequently propelling the growth of the market during the forecast period.


RESTRAINING FACTORS


High Cost of Instruments and Lack of Infrastructure to Restrict the Growth in Emerging Countries


Despite the increasing prevalence of chronic blood diseases and higher demand for blood products and transfusion, there are some factors that are limiting the growth of this market. One of the factors is the lack of spending on healthcare infrastructure and stringent government policies, especially in emerging countries as compared to developed countries.


Additionally, the high cost associated with the tests, instruments, and reagents coupled with the lack of skilled professionals to handle automated diagnostic solutions is one of the certain factors limiting the blood transfusion diagnostics market growth during the forecast period.


SEGMENTATION


By Product Analysis


Reagent & Kits to Dominate the Market in 2020


Among product, the global market is segmented into instruments and reagents and kits. The reagents and kits segment held the dominating share in 2020 owing to the repetitive sales of these products equired for screening and blood group typing both the donor and recipient samples. However, the instruments segment accounted for a comparatively lower share in 2020 due to the higher cost and longer shelf life of these instruments.


By Application Analysis


To know how our report can help streamline your business, Speak to Analyst


Blood Disease Screening to Hold a Dominant Position during the Forecast Period


On the basis of application, the blood transfusion diagnostic market is segmented into blood screening and blood group typing. The blood screening segment dominated the global market in 2020 due to increasing incidences of transfusion transmissible infections (TTI) worldwide.


The blood group typing segment is expected to grow at a significant CAGR owing to the introduction of automated analyzers and increasing demand for group typing and cross-matching tests before transfusion therapy in order to test the compatibility of donor and recipient blood samples.


By End User Analysis


Independent Laboratories & Blood Banks to Register a Higher CAGR During 2021-2028


Based on end user, the market includes hospital-based laboratories and independent laboratories & blood banks. The hospital-based laboratories segment is anticipated to register significant growth during the forecast period due to the increasing number of blood transfusion procedures in hospitals.


In addition, various hospitals are actively implementing blood management programs in order to conserve blood units and facilitate the transfusion process, which is further expected to boost the growth of this segment.


The independent laboratories & blood banks segment dominated the market in 2020. The dominance is attributed to large number of blood transfusions performed in these settings along with the increasing number of stand-alone blood banks & laboratories in developed as well as emerging countries.


REGIONAL INSIGHTS


North America Blood Transfusion Diagnostics Market Size, 2020 (USD Billion)

To get more information on the regional analysis of this market, Request a Free sample


The market size in North America stood at USD 1.66 billion in 2020. The dominance is due to higher adoption of the blood transfusion process, increasing awareness among the general population about blood donations, and established healthcare infrastructure in the region. For instance, according to the data published by the National Centre for Biotechnology Information, in the U.S, nearly 15 million blood units are transfused every year and about 85 million units are transfused worldwide.


The market in Europe is anticipated to grow at a significant CAGR owing to the availability of CE-approved instrument assays for serological and Nucleic Acid Test (NAT) based methods in European countries.


Asia Pacific is expected to register a comparatively higher CAGR during the forecast period. The rapid growth is due to constant initiatives by the government and NGOs in emerging countries to increase awareness regarding blood donations coupled with the presence of a large population suffering from severe blood disorders.


Latin America and the Middle East & Africa are expected to register a moderate CAGR during the forecast period due to the presence of a huge untapped market.


KEY INDUSTRY PLAYERS


Immucor, Inc., Grifols, S.A., and Ortho Clinical Diagnostics are Major Players of the Market


The global blood transfusion diagnostics market is fragmented with players, such as Immucor, Inc., Ortho Clinical Diagnostics. and Grifols, S.A., accounting for a major share in 2020. The robust product portfolio for blood transfusion diagnostics, strong distribution network, and constant focus on research and development are the key factors responsible for the market position of these players.



  • For instance, in October 2019, Ortho Clinical Diagnostics announced the approval of the U.S FDA for the Ortho Sera use on its VISION analyzer. Ortho Sera is a suite of extended antigen phenotyping, which covers over 99.0% of the most commonly tested blood group antigens, offering support to patients with unexpected antibodies.


Grifols S.A., one of the leading players in the market, boasts of a strong diversified portfolio of test kits and products for blood transfusion diagnostics. The company sold over 3 million gel cards in the U.S., in 2019. The company screened an estimated 32 million units of blood in 2019. 


Other players operating in the market are Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, QUOTIENT, Abbott Laboratories, and Merck KGaA.


LIST OF KEY COMPANIES PROFILED:



  • Grifols, S.A. (Barcelona, Spain)

  • Immucor, Inc. (Georgia, United States)

  • Bio-Rad Laboratories, Inc. (California, United States)

  • Ortho Clinical Diagnostics (New Jersey, United States)

  • F. Hoffmann-La Roche Ltd (Basel, Switzerland)

  • QUOTIENT (Eysins, Switzerland)

  • Merck KGaA (Darmstadt, Germany)

  • Abbott (Illinois, United States)

  • Other Players


 KEY INDUSTRY DEVELOPMENTS:



  • April 2021 – EryPharm introduced an advanced technology in the market which can produce red blood cells in large volume and can develop new sourcing for blood transfusion. The company is planning to enter a pilot production phase and increase the production of Cultured Red Blood Cells (cRBC) using Hematopoietic Stem Cells (HSC).

  • March 2021 – F. Hoffmann-La Roche Ltd and Bio-Rad Laboratories, Inc., entered into a global partnership agreement in order to provide the customers access to Bio-Rad’s complete line of InteliQ products and Unity QC data management solutions.

  • February 2019 – Torax Biosciences Limited launched its B2B IVD bulk reagents for latex serology and blood grouping assays in the market. The company aims to provide visual latex agglutination assays ASO, CRP and RF and blood grouping assays in a FFMU formats or filled formats to its distribution partners, manufacturing companies or hospitals.


REPORT COVERAGE


An Infographic Representation of Blood Transfusion Diagnostics Market

To get information on various segments, share your queries with us



The blood transfusion diagnostics market research report provides a detailed analysis of the market and focuses on key aspects such as leading companies, products, applications and end users. Besides this, it offers insights into the market trends and highlights key industry developments. In addition to the aforementioned factors, the report encompasses several factors that have contributed to the growth of the advanced market over recent years.


Report Scope & Segmentation












































  ATTRIBUTE



  DETAILS



Study Period



  2017-2028



Base Year



  2020



Forecast Period



   2021-2028



Historical Period



  2017-2019



Unit



Value (USD Billion)



Segmentation



By Product



  • Instruments

  • Kits & Reagents



By Application



  • Blood Screening

  • Blood Group Typing



By End-User



  • Hospital-based Laboratories

  • Independent Laboratories & Blood Banks



 



By Geography



  • North America (By Product, By Application, By End User, and By Country)

    • The U.S. (By Application)

    • Canada (By Application)



  • Europe (By Product, By Application, By End User, and By Country)

    • The U.K. (By Application)

    • Germany (By Application)

    • France (By Application)

    • Italy (By Application)

    • Spain (By Application)

    • Scandinavia (By Application)



  • Asia Pacific (By Product, By Application, By End User, and By Country)

    • China (By Application)

    • Japan (By Application)

    • India (By Application)

    • Australia (By Application)

    • Southeast Asia (By Application)

    • Rest of Asia Pacific (By Application)



  • Latin America (By Product, By Application, By End User, and By Country)

    • Brazil (By Application)

    • Mexico (By Application)

    • Rest of Latin America (By Application)



  • The Middle East & Africa (By Product, By Application, By End User, and By Country)

    • GCC (By Application)

    • South Africa (By Application)

    • Rest of the Middle East & Africa (By Application)





Frequently Asked Questions

Fortune Business Insights says that the global market stood at USD 4.13 billion in 2020 and is projected to reach USD 7.08 billion by 2028.

In 2020, the North America market value stood at USD 1.66 billion.

The market will exhibit steady growth at a CAGR of 7.1% during the forecast period (2021-2028).

Among product, the reagents and kits segment will lead the market.

Rising prevalence of blood related disorders, and increasing incidence of transfusion transmissible infections (TTI) are the key drivers of the market.

Immucor, Inc., Ortho Clinical Diagnostics and Grifols, S.A., are the top players in the market.

Seeking Comprehensive Intelligence on Different Markets?
Get in Touch with Our Experts

Speak to an Expert
Blood Transfusion Diagnostics Market Size, Share and Global Industry Trend Forecast till 2026
  • May, 2021
  • 2020
  • 2017-2019
  • 190

    CHOOSE LICENSE TYPE

  • 4850
    6850
    8850

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X